Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-02

Clinical Trial Update: Identifying the Role of Oxytocin and Vasopressin in the Functioning of Neurocognitive Systems Involved in Mood Disorders

View source ↗

Summary

A completed clinical trial sponsored by the National Institute of Mental Health investigates how oxytocin and vasopressin influence neurocognitive systems impli…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxytocin (Oxytocin)
  • VASOPRESSIN (VASOPRESSIN)

Snippet

Sponsor: National Institute of Mental Health (NIMH) | Conditions: Mood Disorders | Status: COMPLETED